Copa Airlines aircraft will bear the pink ribbon symbol as support for the breast cancer prevention campaign



Panama, October 14, 2011 -- During all of October, Copa Airlines' fleet of aircraft will sport the pink ribbon symbol, which internationally identifies the fight against breast cancer.  This symbol represents the Panamanian airline's commitment to the awareness goals of the Pink Ribbon campaign, held by FundAyuda, with support from the Office of the First Lady of the Republic of Panama.

With this gesture, Copa Airlines gets involved, for the eighth year running, with this campaign that seeks to promote early detection of breast cancer, the most common cancer in women around the world, according to the World Health Organization.

“Just like every year, at Copa we have wanted to demonstrate our solidarity with this campaign for fighting breast cancer, generating awareness regarding disease prevention and timely detection”, said Vidalia de Casado, Copa Airlines Vice President of On-Board Services. “We hope that deploying this symbol on our fleet of aircraft will help increase the visibility of a cause that is very important to us, since breast cancer is the third leading cause of tumors in Panama. With this in mind, our fleet will take the message of this commitment we have taken on as a responsible company to all the countries in Latin America and the Caribbean that we fly to”, she added.

Likewise, Copa Airlines will perform internal sensitization actions, as this year, like every year, its head offices, as well as its offices at the Hub of the Americas, will remind its staff of disease prevention messages using different forms of communication.

Recent national statistics indicate breast cancer is the fifth cause of mortality due to tumors in the country and, according to the World Health Organization, breast cancer is the leading cause of death in women, both in developed and in developing countries. In this sense, early detection plays an important role for improving the prognosis and the survival of breast cancer patients.